Allos Therapeutics, Inc. Merger Litigation (Nasdaq: ALTH)

Law Office of Brodsky & Smith, LLC Announces Investigation of Allos Therapeutics, Inc. 
 
BALA CYNWYD – (BUSINESS WIRE) Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Allos Therapeutics, Inc. (“Allos” or the “Company”) (Nasdaq - ALTH- News) relating to the proposed acquisition by AMAG Pharmaceuticals, Inc (Nasdaq – AMAG) (“AMAG”).  
 
Under the terms of the transaction Allos shareholders would receive a fixed ratio of 0.1282 shares of AMAG stock for each share Allos stock they own. The transaction values Allos stock at approximately $2.44 a share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Allos for not acting in the Company’s shareholders' best interests in connection with the sale process to AMAG. The transaction may undervalue Allos as Allos stock traded at $2.96 as recently as May 2, 2011 and traded at $5.77 on July 23, 2010. Additionally, an analyst has set a price target of $8.00 for the Company.  
 
If you own shares of Allos stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, or by calling toll free 877-LEGAL-90. 

To Join the Allos Therapeutics, Inc. Litigation

1. Fill out this form

   Mr/Mrs/Ms --Select a title-- Mr. Mrs. Ms.

   First Name: Required

   Last Name:Required

   
   

   Address: Required

   City: Required

   State: Required Select a State AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY

   
   

   Email Address:Required

   Phone Number:Required

   
   

   Number of Shares Owned:Required

   Date purchased:

   
   

   By clicking on the submit button, I acknowledge that I have downloaded and read both the Merger Class Action Lawsuit Retainer Agreement and Class Representative Rights and Responsibilities documents, and agree to retain Brodsky & Smith, LLC to file an action against Allos Therapeutics, Inc. in connection with this case. Brodsky & Smith, LLC will prosecute the action on a contingent fee basis and will advance all costs and expenses.
   

View Complaint

The complaint is unavailable at this time

Join Other Cases

Frequently Asked Questions

 

Home : All cases : Report a Fraud

FAQ's : Attorneys : Practice Areas : Contact Us : Links : Disclaimer